D van Assche

525 total citations
8 papers, 393 citations indexed

About

D van Assche is a scholar working on Dermatology, Immunology and Allergy and Complementary and alternative medicine. According to data from OpenAlex, D van Assche has authored 8 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Dermatology, 4 papers in Immunology and Allergy and 2 papers in Complementary and alternative medicine. Recurrent topics in D van Assche's work include Allergic Rhinitis and Sensitization (4 papers), Dermatology and Skin Diseases (4 papers) and Complementary and Alternative Medicine Studies (2 papers). D van Assche is often cited by papers focused on Allergic Rhinitis and Sensitization (4 papers), Dermatology and Skin Diseases (4 papers) and Complementary and Alternative Medicine Studies (2 papers). D van Assche collaborates with scholars based in Switzerland, Germany and Netherlands. D van Assche's co-authors include Stephen P. McKenna, D Whalley, Diane Whalley, Jasper Huels, Sharon A. Cook, B. Crickx, Lynda Doward, Thomas Kohlmann, Feride Frech and Mauro Niero and has published in prestigious journals such as PEDIATRICS, Tetrahedron Letters and British Journal of Dermatology.

In The Last Decade

D van Assche

7 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D van Assche Switzerland	6	296	186	103	65	38	8	393
N. Franzke Germany	9	310 1.0×	134 0.7×	131 1.3×	78 1.2×	32 0.8×	18	432
Natasha K Rogers United Kingdom	13	311 1.1×	255 1.4×	55 0.5×	147 2.3×	13 0.3×	30	476
Grèce Saba France	9	303 1.0×	254 1.4×	25 0.2×	140 2.2×	42 1.1×	17	500
Seema P. Kini United States	7	257 0.9×	93 0.5×	44 0.4×	50 0.8×	13 0.3×	9	362
Chih-ho Hong Canada	11	219 0.7×	128 0.7×	86 0.8×	85 1.3×	11 0.3×	27	298
Helen Nankervis United Kingdom	12	490 1.7×	429 2.3×	27 0.3×	233 3.6×	25 0.7×	25	606
M. J. van Geel Netherlands	10	211 0.7×	35 0.2×	300 2.9×	34 0.5×	29 0.8×	12	383
Cecilia Ganslandt Denmark	10	222 0.8×	34 0.2×	259 2.5×	26 0.4×	31 0.8×	17	353
Louise A. A. Gerbens Netherlands	13	548 1.9×	454 2.4×	40 0.4×	264 4.1×	18 0.5×	36	626
M.V. Kuipers Netherlands	6	198 0.7×	27 0.1×	224 2.2×	10 0.2×	33 0.9×	8	329

Countries citing papers authored by D van Assche

Since Specialization

Citations

This map shows the geographic impact of D van Assche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D van Assche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D van Assche more than expected).

Fields of papers citing papers by D van Assche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D van Assche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D van Assche. The network helps show where D van Assche may publish in the future.

Co-authorship network of co-authors of D van Assche

This figure shows the co-authorship network connecting the top 25 collaborators of D van Assche. A scholar is included among the top collaborators of D van Assche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D van Assche. D van Assche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

McKenna, SP, D Whalley, Y. De Prost, et al.. (2006). Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981): impact on quality of life and health‐related quality of life. Journal of the European Academy of Dermatology and Venereology. 20(3). 248–254. 32 indexed citations

McKenna, Stephen P., Diane Whalley, Ruud A.M. Erdman, et al.. (2005). International development of the Parents’ Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Quality of Life Research. 14(1). 231–241. 67 indexed citations

Whalley, D, S. P. McKenna, Rudolph A. M. Erdman, et al.. (2004). A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). British Journal of Dermatology. 150(2). 274–283. 102 indexed citations

McKenna, Stephen P., Sharon A. Cook, D Whalley, et al.. (2003). Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. British Journal of Dermatology. 149(2). 323–331. 108 indexed citations

Grueger, Jens & D van Assche. (2002). PES1 COST EFFECTIVENESS OF PIMECROLIMUS (ELIDEL) IN THE TREATMENT OF CHILDREN WITH ATOPIC DERMATITIS. Value in Health. 5(6). 556–556. 1 indexed citations

Whalley, Diane, Jasper Huels, Stephen P. McKenna, & D van Assche. (2002). The Benefit of Pimecrolimus (Elidel, SDZ ASM 981) on Parents’ Quality of Life in the Treatment of Pediatric Atopic Dermatitis. PEDIATRICS. 110(6). 1133–1136. 73 indexed citations

Shear, Neil H., Thomas R. Einarson, Steven R. Arikian, John Doyle, & D van Assche. (1998). Pharmacoeconomic analysis of topical treatments for tinea infections. International Journal of Dermatology. 37(1). 64–71. 9 indexed citations

Fleury, Jean‐Pierre, et al.. (1965). Le dicyanomethyl-1 p. toluene sulfonyl-3 triazene-1, intermediaire stable dans la synthese des derives diazoiques selon doering.. Tetrahedron Letters. 6(19). 1399–1403. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact